Samsara BioCapital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001744967 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 14, 2020

Total Value: $311M (100.0% shares, 0.0% debt)

Holdings (32)

— Forma Therapeutics Holdings, Inc. 23.6%

Value $73.38M Shares 1,578,388 Est. Cost $46.49 Unrealized —

— Springworks Therapeutics Inc 7.5%

Value $23.41M Shares 557,356 Est. Cost $21.68 Unrealized —

— Odonate Therapeutics Inc 6.8%

Value $21.02M Shares 496,505 Est. Cost $14.81 Unrealized —

— Principia Biopharma Inc 6.6%

Value $20.5M Shares 342,946 Est. Cost $34.91 Unrealized —

— Intercept Pharmaceuticals Inc 6.2%

Value $19.34M Shares 403,688 Est. Cost $88.27 Unrealized —

— Allakos Inc 5.6%

Value $17.52M Shares 243,868 Est. Cost $51.45 Unrealized —

— Iveric Bio, Inc. 5.5%

Value $17.19M Shares 3,370,478 Est. Cost $5.74 Unrealized —

— Syros Pharmaceuticals Inc 5.1%

Value $15.87M Shares 1,571,903 Est. Cost $6.82 Unrealized —

— Sutro BioPharma Inc 4.2%

Value $13M Shares 1,675,579 Est. Cost $8.61 Unrealized —

— Atreca Inc 3.5%

Value $10.86M Shares 510,296 Est. Cost $18.84 Unrealized —

— Aeglea BioTherapeutics, Inc. 2.9%

Value $8.949M Shares 967,500 Est. Cost $9.25 Unrealized —

GERN Genron Corporation 2.7%

Value $8.481M Shares 3,890,220 Est. Cost $1.49 Unrealized 0.0%

— Aravive Inc 2.2%

Value $6.705M Shares 576,066 Est. Cost $5.87 Unrealized —

RYTM Rhythm Pharmaceuticals Inc 2.0%

Value $6.161M Shares 276,289 Est. Cost $17.90 Unrealized +8.9%

FULC Fulcrum Therapeutics, Inc. 1.7%

Value $5.379M Shares 294,118 Est. Cost $15.75 Unrealized 0.0%

— Portola Pharmaceuticals Inc 1.7%

Value $5.279M Shares 318,429 Est. Cost $11.84 Unrealized —

— Pieris Pharmaceuticals Inc 1.7%

Value $5.203M Shares 1,620,249 Est. Cost $2.86 Unrealized —

— Hookipa Pharma Inc 1.5%

Value $4.651M Shares 400,245 Est. Cost $6.73 Unrealized —

ACRS Aclaris Therapeutics, Inc. 1.4%

Value $4.225M Shares 2,608,117 Est. Cost $1.36 Unrealized -1.6%

— Aimmune Therapeutics, Inc. 1.3%

Value $3.886M Shares 232,571 Est. Cost $14.42 Unrealized —

— Kala Pharmaceuticals Inc 1.1%

Value $3.564M Shares 339,102 Est. Cost $10.18 Unrealized —

— Bellus Health Inc 1.1%

Value $3.45M Shares 333,631 Est. Cost $7.55 Unrealized —

RCKT Rocket Pharmaceuticals Inc 0.9%

Value $2.892M Shares 138,197 Est. Cost $19.67 Unrealized -8.4%

KALV KalVista Pharmaceuticals Inc 0.7%

Value $2.035M Shares 168,174 Est. Cost $18.15 Unrealized -41.4%

— Catabasis Pharmaceuticals Inc 0.6%

Value $1.929M Shares 300,000 Est. Cost $4.37 Unrealized —

— Soleno Therapeutics, Inc. 0.5%

Value $1.665M Shares 750,000 Est. Cost $2.22 Unrealized —

UROV Urovant Sciences Ltd 0.5%

Value $1.55M Shares 157,480 Est. Cost $6.59 Unrealized —

— NGM Biopharmaceuticals, Inc. 0.3%

Value $959K Shares 48,602 Est. Cost $19.73 Unrealized —

— Assembly Biosciences Inc. 0.2%

Value $694K Shares 29,740 Est. Cost $23.34 Unrealized —

— Akero Therapeutics, Inc. 0.2%

Value $554K Shares 22,234 Est. Cost $21.20 Unrealized —

— Amarin Corp PLC 0.1%

Value $346K Shares 50,000 Est. Cost $4.00 Unrealized —

— Verona Pharma PLC. 0.1%

Value $203K Shares 43,456 Est. Cost $4.67 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Forma Therapeutics Holdings, Inc.	1,578,388	$73.38M	23.6%	$46.49	—	COM	34633R104
—	Springworks Therapeutics Inc	557,356	$23.41M	7.5%	$21.68	—	COM	85205L107
—	Odonate Therapeutics Inc	496,505	$21.02M	6.8%	$14.81	—	COM	676079106
—	Principia Biopharma Inc	342,946	$20.5M	6.6%	$34.91	—	COM	74257L108
—	Intercept Pharmaceuticals Inc	403,688	$19.34M	6.2%	$88.27	—	COM	45845P108
—	Allakos Inc	243,868	$17.52M	5.6%	$51.45	—	COM	01671P100
—	Iveric Bio, Inc.	3,370,478	$17.19M	5.5%	$5.74	—	COM	46583P102
—	Syros Pharmaceuticals Inc	1,571,903	$15.87M	5.1%	$6.82	—	COM	87184Q107
—	Sutro BioPharma Inc	1,675,579	$13M	4.2%	$8.61	—	COM	869367102
—	Atreca Inc	510,296	$10.86M	3.5%	$18.84	—	COM	04965G109
—	Aeglea BioTherapeutics, Inc.	967,500	$8.949M	2.9%	$9.25	—	COM	00773J103
GERN	Genron Corporation	3,890,220	$8.481M	2.7%	$1.49	0.0%	COM	374163103
—	Aravive Inc	576,066	$6.705M	2.2%	$5.87	—	COM	03890D108
RYTM	Rhythm Pharmaceuticals Inc	276,289	$6.161M	2.0%	$17.90	+8.9%	COM	76243J105
FULC	Fulcrum Therapeutics, Inc.	294,118	$5.379M	1.7%	$15.75	0.0%	COM	359616109
—	Portola Pharmaceuticals Inc	318,429	$5.279M	1.7%	$11.84	—	COM	737010108
—	Pieris Pharmaceuticals Inc	1,620,249	$5.203M	1.7%	$2.86	—	COM	720795103
—	Hookipa Pharma Inc	400,245	$4.651M	1.5%	$6.73	—	COM	43906K100
ACRS	Aclaris Therapeutics, Inc.	2,608,117	$4.225M	1.4%	$1.36	-1.6%	COM	00461U105
—	Aimmune Therapeutics, Inc.	232,571	$3.886M	1.3%	$14.42	—	COM	00900T107
—	Kala Pharmaceuticals Inc	339,102	$3.564M	1.1%	$10.18	—	COM	483119103
—	Bellus Health Inc	333,631	$3.45M	1.1%	$7.55	—	COM	07987C204
RCKT	Rocket Pharmaceuticals Inc	138,197	$2.892M	0.9%	$19.67	-8.4%	COM	77313F106
KALV	KalVista Pharmaceuticals Inc	168,174	$2.035M	0.7%	$18.15	-41.4%	COM	483497103
—	Catabasis Pharmaceuticals Inc	300,000	$1.929M	0.6%	$4.37	—	COM	14875P206
—	Soleno Therapeutics, Inc.	750,000	$1.665M	0.5%	$2.22	—	COM	834203200
UROV	Urovant Sciences Ltd	157,480	$1.55M	0.5%	$6.59	—	COM	G9381B108
—	NGM Biopharmaceuticals, Inc.	48,602	$959K	0.3%	$19.73	—	COM	62921N105
—	Assembly Biosciences Inc.	29,740	$694K	0.2%	$23.34	—	COM	045396108
—	Akero Therapeutics, Inc.	22,234	$554K	0.2%	$21.20	—	COM	00973Y108
—	Amarin Corp PLC	50,000	$346K	0.1%	$4.00	—	SPONS ADR NEW	023111206
—	Verona Pharma PLC.	43,456	$203K	0.1%	$4.67	—	SPONSORED ADS	925050106